Pharmacogenomics & Pharmacoproteomics
Pharmacogenomics is the study of genes and their functions that affect a person's response to drugs. The genetic makeup of a personal affects response to medication is analysed by Pharmacogenomics. Personalized medicine is a customized medical treatment to the individual features of each patient. Rapid advancing field is Pharmacoproteomics during which the techniques of genetics square measure applied to develop pharmaceutical agents. The impact of illness or medication will substitute for far more advanced assays in pharmacodynamics at a lower price in time, financial output,and clinical risk within the study is that the full set of proteins usage.
- New approaches
- Warfarin sensitivity and resistance
- Malignant hyperthermia
- Epidermal necrolysis
- Drug-metabolizing enzymes
- Clinical implementation
- Polypharmacy
Related Conference of Pharmacogenomics & Pharmacoproteomics
July 20-21, 2026
7th International Conference on Applied Microbiology and Infectious Diseases
London, UK
August 27-28, 2026
12th International Congress on Trauma, Critical Care and Emergency Medicine
Paris, France
September 07-08, 2026
21st International Conference on Virology, Emerging Diseases & vaccines
London, UK
November 16-17, 2026
9th International Conference on Antimicrobial and Antibacterial Agents
Tokyo, Japan
November 16-17, 2026
10th International Conference on Microbiome, Probiotics & Gut Nutrition
San Francisco, USA

